Conservative medical therapy for a macroprolactinoma presenting with obstructive hydrocephalus.

BMJ Case Rep

Section of Neurosurgery, Department of Neurosciences, Philippine General Hospital, University of the Philippines Manila, Manila, Metro Manila, Philippines.

Published: January 2025

Obstructive hydrocephalus is a rare complication of pituitary prolactinomas, especially in women, where symptoms of amenorrhoea rarely go unnoticed. In this study, a case of a female in her 20s with a 2-month history of frontotemporal headache, acutely worsening over 3 days, is presented. Cranial imaging showed a sellar-suprasellar mass (2.6 × 3.5 × 3.6 cm) with associated obstructive hydrocephalus and tonsillar herniation. Hyperprolactinaemia was confirmed, and cabergoline was initiated. Clinically, the patient's headache resolved within 24 hours of the first dose, and repeat prolactin levels fell by 96% within the first month. Repeat imaging confirmed the resolution of the obstructive hydrocephalus within 4 weeks. The patient was able to return to her work, and her menses resumed more than a year later. This case and the corresponding review of the literature demonstrate the possible utility of medical management in cases of obstructive hydrocephalus secondary to a macroprolactinoma.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2024-261540DOI Listing

Publication Analysis

Top Keywords

obstructive hydrocephalus
20
obstructive
5
hydrocephalus
5
conservative medical
4
medical therapy
4
therapy macroprolactinoma
4
macroprolactinoma presenting
4
presenting obstructive
4
hydrocephalus obstructive
4
hydrocephalus rare
4

Similar Publications

We report a rare clinical presentation of a 54-year-old male diagnosed with infective endocarditis caused by , a nutritionally variant streptococcus (NVS) characterized by unique growth requirements and high pathogenic potential. The patient presented with prolonged fever and residual hemiparesis following an ischemic stroke. Blood culture confirmed , and imaging identified vegetations on a bicuspid aortic valve.

View Article and Find Full Text PDF

Introduction: Focal impaired awareness seizures are a common neurological disorder characterized by abnormal electrical activity in a specific brain region, resulting in impaired consciousness and neurological symptoms. Treatment options for patients may include antiepileptic medications, lifestyle modifications, or, in some cases, surgical intervention aimed at resecting the area of the brain responsible for seizure generation. Shunt malfunction can lead to seizures in cases of hydrocephalus; however, seizures triggered by stimulation of a specific brain area by the shunt catheter post-placement have not been reported.

View Article and Find Full Text PDF

Background: Hydrocephalus is a condition characterized by the accumulation of cerebrospinal fluid (CSF) in the ventricular system due to various causes, including excessive CSF production, impaired circulation, or absorption dysfunction. This condition is often accompanied by ventricular enlargement, compression of brain parenchyma, and increased intracranial pressure. Ventriculoperitoneal (VP) shunting is the first-line treatment for hydrocephalus; however, when the peritoneal catheter becomes obstructed due to encapsulation, the procedure may need to be converted to a ventriculoatrial (VA) shunt, which serves as a second-line treatment.

View Article and Find Full Text PDF

Osteogenesis imperfecta is a genetic condition with improperly or inadequately produced Type I collagen. Manifestations include bowing deformities, fractures, hydrocephalus, respiratory insufficiency, and feeding difficulty. Moderate or severe OI is often diagnosed prenatally based on ultrasound findings and genetic testing may be labeled as lethal.

View Article and Find Full Text PDF

This study aimed to investigate the feasibility, acceptability, and preliminary efficacy of a ventriculosagittal sinus (VSS) shunt in the treatment of hydrocephalus with elevated cerebrospinal fluid (CSF) protein content. In this single-center retrospective analysis, we enrolled 80 patients with hydrocephalus and elevated CSF protein levels. Based on these procedures, primary cohort was divided into two groups using CSF protein (CSFP) for subsequent analysis to determine the relationship between the clinical effect and CSFP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!